Siga Technologies INC Total Contract Liability
Siga Technologies INC (SIGA) had Total Contract Liability of $4.16 million as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2019-03-06
- 2018-12-31: Contract with Customer, Liability $4.16M.
- 2018-09-30: Contract with Customer, Liability $684.23K.
- 2018-06-30: Contract with Customer, Liability $376.56M.
- 2018-03-31: Contract with Customer, Liability $377.29M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2018-12-31 | $4.16M 10-K · filed 2019-03-06 |
| 2018-09-30 | $684.23K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $376.56M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $377.29M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $378.90M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |